Intelligencer
The Cut
Vulture
The Strategist
Curbed
Grub Street
Magazine
Subscribe to the Magazine
Give a Gift Subscription
Buy Back Issues
Current Issue Contents
New York
Shop
Subscribe
Sign In
Account
Profile
Sign Out
Menu
Menu
Close
Close
Search
Intelligencer
Politics
Technology
Business
Ideas
The Cut
Style
Self
Culture
Power
The Cut Shop
Vulture
TV
Movies
Comedy
Music
Books
Art
Theater
What to Stream
Curbed
Cityscape
Design Hunting
The Real Estate
Best of New York
The Strategist
Gift Guides
Sales
Beauty
Home
Kitchen + Dining
Fashion
Travel
Tech & Electronics
Fitness
Kids & Babies
Grub Street
Restaurants & Bars
The Thousand Best
The Magazine
Crossword
Current Issue
Subscribe
Gift Subscriptions
Buy Back Issues
More
About
New York
Shop
Newsletters
Podcasts
Videos
Best Doctors
Top Rated Lawyers
Sign In
Subscribe
Search
Like Us
Follow Us
Follow
Search
Search
Close
Subscribe
Give A
Gift
Menu
Menu
Close
Close
Search
Intelligencer
Politics
Technology
Business
Ideas
The Cut
Style
Self
Culture
Power
The Cut Shop
Vulture
TV
Movies
Comedy
Music
Books
Art
Theater
What to Stream
Curbed
Cityscape
Design Hunting
The Real Estate
Best of New York
The Strategist
Gift Guides
Sales
Beauty
Home
Kitchen + Dining
Fashion
Travel
Tech & Electronics
Fitness
Kids & Babies
Grub Street
Restaurants & Bars
The Thousand Best
The Magazine
Crossword
Current Issue
Subscribe
Gift Subscriptions
Buy Back Issues
More
About
New York
Shop
Newsletters
Podcasts
Videos
Best Doctors
Top Rated Lawyers
Sign In
Subscribe
Search
Like Us
Follow Us
Follow
Search
Search
Close
Displaying all articles tagged:
Epipens
Oct. 26, 2016
A Competitor to the EpiPen Will Go Back on the Market in 2017
Will it affect the price of the anti-allergy drug?
By
Jen Kirby
Sept. 21, 2016
Democrats and Republicans Unite to Rip Mylan CEO for EpiPen Price Hikes
Finally, something they can agree on.
By
Adam K. Raymond
Sept. 2, 2016
Clinton Reveals New Plan to Help Americans Score Cheaper Drugs
As EpiPens become luxury goods, the Democratic nominee unveils a plan for reining in drug prices.
By
Eric Levitz